drugset / Trial / NCT01506726

Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia

NCT01506726

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether treatment of unexplained anemia in older adults and elevated inflammatory markers with oral salsalate can improve hemoglobin levels and improve physical activity and quality of life.

Timeline

Start
2012-03
Primary completion
2014-10
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Salsalate Small molecule 1500 mg Oral

Indications